EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Value-based health care frameworks for the health technology assessments of “omics” technologies: an international survey

Tommaso Osti iD, Abdelrahman Taha, Eva Reviriego-Rodrigo iD, Roberta Pastorino, Stefania Boccia, Iñaki Gutierrez-Ibarluzea iD

International Journal of Technology Assessment in Health Care · 2025

DOI: 10.1017/s0266462325103279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Technology Assessment in Health Care, 2025. Verfasst von Tommaso Osti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Public Health, Section of Hygiene, https://ror.org/03h7r5v07Universita Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Genomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite omics technologies gaining traction in clinical settings, particularly in oncology, challenges persist in their widespread adoption due to the pre-requisite robust evidence supporting efficacy and cost-effectiveness. This study aims to explore the experiences of organizations working in the health technology assessment (HTA) field in evaluating omics technologies, with a particular focus on the adoption and application of specific assessment frameworks.

Methods

We conducted a global survey to gather insights into current practices and frameworks used in HTA evaluations of omics technologies.

Results

We gathered responses from thirty-nine participants representing organizations across twenty-nine countries and five continents. Among them, 51 percent (n = 20) reported experience in evaluating omics technologies, including multi-omics tests for early disease detection, biomarker-based cancer diagnostics, and advanced genomic sequencing techniques. Only three organizations employed specific assessment frameworks: the Adelaide Health Technology Assessment Agency in Australia, the Netherlands Cancer Institute , and the Andalusian HTA Agency in Spain. These frameworks address key evaluation aspects such as analytical and clinical validity, clinical and personal utility, organizational impact, and ethical, legal, and social implications of omics technologies.

Discussion

Despite their relevance, the limited adoption of tailored frameworks highlights the need for more structured and context-specific approaches to facilitate the integration of omics technologies into healthcare systems. Collaborative efforts among stakeholders, including patients, healthcare providers, policymakers, and industry representatives, are crucial for devising robust evaluation strategies addressing the complexities of omics technologies comprehensively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalGenomicsHumansSurveys and QuestionnairesCost-Benefit AnalysisInternationalityValue-Based Health Care

Stichwörter der Autor:innen

assessment frameworkgenomicshealth technology assessmentpersonalised medicineprecision medicinevalue-based healthcare

Autor:innen und Institutionen

  • Department of Life Sciences and Public Health, Section of Hygiene, https://ror.org/03h7r5v07Universita Cattolica del Sacro Cuore, Rome, Italy.
  • Basque Office for Health Technology Assessment, BIOEF, https://ror.org/054hj6489Basque Foundation for Health Innovation and Research, Barakaldo, Spain.
  • Departments of Woman and Child Health and Public Health, https://ror.org/00rg70c39Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Health Research, Innovation and Evaluation Directorate, https://ror.org/00pz2fp31Ministry for Health, Basque Government, Bilbao, Spain.

ORCID-Profile: Tommaso Osti, Eva Reviriego-Rodrigo, Iñaki Gutierrez-Ibarluzea

Förderung

  • HORIZON EUROPE Marie Sklodowska-Curie Actions

Zitieren

APA

Osti, T., Taha, A., Reviriego-Rodrigo, E., Pastorino, R., Boccia, S., & Gutierrez-Ibarluzea, I. (2025). Value-based health care frameworks for the health technology assessments of “omics” technologies: an international survey. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462325103279

Vancouver

Osti T, Taha A, Reviriego-Rodrigo E, Pastorino R, Boccia S, Gutierrez-Ibarluzea I. Value-based health care frameworks for the health technology assessments of “omics” technologies: an international survey. International Journal of Technology Assessment in Health Care. 2025. doi:10.1017/s0266462325103279

BibTeX
@article{Osti2025,
  author = {Osti, Tommaso and Taha, Abdelrahman and Reviriego-Rodrigo, Eva and Pastorino, Roberta and Boccia, Stefania and Gutierrez-Ibarluzea, Iñaki},
  title = {Value-based health care frameworks for the health technology assessments of “omics” technologies: an international survey},
  journal = {International Journal of Technology Assessment in Health Care},
  year = {2025},
  doi = {10.1017/s0266462325103279}
}
Kostenlos starten →